Shu Wen Li

Aggregation of α-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine

W. J. Burke, Vijaya B. Kumar, Neeraj Pandey et al. · Acta Neuropathologica · 2007 · 236 citations

Neurodegenerative Diseases, Molecular Neuroscience, Biochemistry +12

3,4-Dihydroxyphenylacetaldehyde is the toxic dopamine metabolite in vivo: implications for Parkinson’s disease pathogenesis

W. J. Burke, Shu Wen Li, Evelyn A. Williams et al. · Brain Research · 2003 · 208 citations

Neurodegenerative Diseases, Toxic Dopamine Metabolite, Medicine +12

Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: mechanism of neuron death

W. J. Burke, Shu Wen Li, Catherine A. Schmitt et al. · Brain Research · 1999 · 81 citations

Neurotoxicology, Neuron Death, Alzheimer's Disease +10

Norepinephrine transmitter metabolite generates free radicals and activates mitochondrial permeability transition: a mechanism for DOPEGAL-induced apoptosis

W. J. Burke, Bruce S. Kristal, Byung P. Yu et al. · Brain Research · 1998 · 63 citations · Full text

Mitochondrial Pt, Mitochondrial Function, Biochemistry +14

Quantitation of 3,4-Dihydroxyphenylacetaldehyde and 3,4-Dihydroxyphenylglycolaldehyde, the Monoamine Oxidase Metabolites of Dopamine and Noradrenaline, in Human Tissues by Microcolumn High-Performance Liquid Chromatography

W. J. Burke, Hyung D. Chung, Shu Wen Li · Analytical Biochemistry · 1999 · 43 citations

Psychoactive Drug, Monoamine Oxidase Metabolites, Biochemistry +8